From: Miguel Negron [Miguel.Negron@molnlycke.net]
Sent: Monday, October 28, 2002 12:00 PM
To: FDADockets@oc.fda.gov
Subject: Docket No. 02N-0445

To Whom It May Concern:

I will like to register to attend the upcoming FDA Public Hearing on FDA Regulation of Combination Products (November 25, 2002).  I will not be making any presentation.

Best Regards,

Miguel A. Negron 
VP Quality & Regulatory Affairs - North America
Mölnlycke Health Care, Inc.
mobile: 609-865-6421
land: 267-685-2078
fax: 267-685-2010 (public) 
Confidentiality Notice: This e-mail transmission may contain confidential or legally privileged information intended only for the individual or entity named in the e-mail address. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please reply to the sender, so that Mölnlycke Health Care can arrange for proper delivery, and please delete the message from your inbox. Thank you.